{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:33Z","timestamp":1772119473824,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01970-y","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T15:13:16Z","timestamp":1766848396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic implications of CD15 antigen expression in patients with acute myeloid leukemia"],"prefix":"10.1007","volume":"26","author":[{"given":"Zhen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiegang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangnian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"issue":"29","key":"1970_CR1","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","volume":"34","author":"C Ganzel","year":"2016","unstructured":"Ganzel C, Manola J, Douer D, Rowe JM, Fernandez HF, Paietta EM, et al. Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN cancer research group trials, 1980\u20132008. J Clin Oncol. 2016;34(29):3544\u201353.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1970_CR2","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-024-01143-2","volume":"14","author":"H Kantarjian","year":"2024","unstructured":"Kantarjian H, Borthakur G, Daver N, DiNardo CD, Issa G, Jabbour E, et al. Current status and research directions in acute myeloid leukemia. Blood Cancer J. 2024;14(1):163.","journal-title":"Blood Cancer J"},{"issue":"10147","key":"1970_CR3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593\u2013606.","journal-title":"Lancet"},{"key":"1970_CR4","doi-asserted-by":"crossref","unstructured":"Ruhnke L, Bill M, Zukunft S, Eckardt JN, Sch\u00e4fer S, Stasik S, Hanoun M, Schroeder T, Fransecky L, Steffen B et al. Validation of the revised 2022 European leukemiaNet risk stratification in adult patients with acute myeloid leukemia. Blood Adv.2025;9(6):1392-1404.","DOI":"10.1182\/bloodadvances.2024013304"},{"issue":"2","key":"1970_CR5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2017.09.001","volume":"32","author":"AP Jillella","year":"2018","unstructured":"Jillella AP, Kota VK. The global problem of early deaths in acute promyelocytic leukemia: a strategy to decrease induction mortality in the most curable leukemia. Blood Rev. 2018;32(2):89\u201395.","journal-title":"Blood Rev"},{"key":"1970_CR6","doi-asserted-by":"crossref","unstructured":"Lins MM, Mello MJG, Ribeiro RC, De Camargo B F\u00e1tima Pessoa Milit\u00e3o, de Albuquerque M, Thuler LCS. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country. Ann Hematol 2019, 98(6):1403\u20131411.","DOI":"10.1007\/s00277-019-03661-7"},{"issue":"12","key":"1970_CR7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"3","key":"1970_CR8","first-page":"424","volume":"72","author":"A Jawad","year":"2022","unstructured":"Jawad A, Khan SA, Uddin N, Ahmad D, Tipu HN, Akhtar F. Aberrant expression of myeloid antigens in patients of acute lymphoblastic leukaemia. J Pak Med Assoc. 2022;72(3):424\u20139.","journal-title":"J Pak Med Assoc"},{"issue":"4","key":"1970_CR9","first-page":"274","volume":"14","author":"LHS Pinheiro","year":"2020","unstructured":"Pinheiro LHS, Trindade LD, Costa FO, Silva NL, Sandes AF, Nunes MAP, et al. Aberrant phenotypes in acute myeloid leukemia and its relationship with prognosis and survival: a systematic review and meta-analysis. Int J Hematol Oncol Stem Cell Res. 2020;14(4):274\u201388.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"19","key":"1970_CR10","doi-asserted-by":"crossref","first-page":"16100","DOI":"10.1074\/jbc.M007272200","volume":"276","author":"F Nakayama","year":"2001","unstructured":"Nakayama F, Nishihara S, Iwasaki H, Kudo T, Okubo R, Kaneko M, Nakamura M, Karube M, Sasaki K, Narimatsu H. CD15 expression in mature granulocytes is determined by alpha 1,3-fucosyltransferase IX, but in promyelocytes and monocytes by alpha 1,3-fucosyltransferase IV. J Biol Chem. 2001;276(19):16100\u20136.","journal-title":"J Biol Chem"},{"issue":"5","key":"1970_CR11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/neuonc\/nov248","volume":"18","author":"SA Jassam","year":"2016","unstructured":"Jassam SA, Maherally Z, Smith JR, Ashkan K, Roncaroli F, Fillmore HL, et al. TNF-\u03b1 enhancement of CD62E mediates adhesion of non-small cell lung cancer cells to brain endothelium via CD15 in lung-brain metastasis. Neuro Oncol. 2016;18(5):679\u201390.","journal-title":"Neuro Oncol"},{"issue":"6","key":"1970_CR12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.stem.2007.10.001","volume":"1","author":"R Majeti","year":"2007","unstructured":"Majeti R, Park CY, Weissman IL. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell. 2007;1(6):635\u201345.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"1970_CR13","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V77.6.1218.1218","volume":"77","author":"LW Terstappen","year":"1991","unstructured":"Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34\u2009+\u2009CD38- progenitor cells. Blood. 1991;77(6):1218\u201327.","journal-title":"Blood"},{"issue":"7","key":"1970_CR14","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2007-03-083048","volume":"110","author":"A van Rhenen","year":"2007","unstructured":"van Rhenen A, van Dongen GA, Kelder A, Rombouts EJ, Feller N, Moshaver B, Stigter-van Walsum M, Zweegman S, Ossenkoppele GJ, Jan Schuurhuis G. The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood. 2007;110(7):2659\u201366.","journal-title":"Blood"},{"key":"1970_CR15","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.3390\/cancers14092203","volume":"14(9)","author":"W Szlasa","year":"2022","unstructured":"Szlasa W, Wilk K, Knecht-Gurwin K, Gurwin A, Fro\u0144 A, Sauer N, et al. Prognostic and therapeutic role of CD15 and CD15s in cancer. Cancers (Basel). 2022;14(9):2203.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1970_CR16","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hon.2331","volume":"35","author":"M Chisini","year":"2017","unstructured":"Chisini M, Stefanizzi C, Ceglie T, Raponi S, Vozella F, Colafigli G, Salaroli A, D\u2019Angi\u00f2 M, Mancini M, Diverio D, et al. Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia. Hematol Oncol. 2017;35(4):804\u20139.","journal-title":"Hematol Oncol"},{"issue":"20","key":"1970_CR17","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood"},{"issue":"1","key":"1970_CR18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjh.14523","volume":"177","author":"B Buldini","year":"2017","unstructured":"Buldini B, Rizzati F, Masetti R, Fagioli F, Menna G, Micalizzi C, et al. Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002\/01 study protocol. Br J Haematol. 2017;177(1):116\u201326.","journal-title":"Br J Haematol"},{"issue":"4","key":"1970_CR19","first-page":"1220","volume":"84","author":"K Bradstock","year":"1994","unstructured":"Bradstock K, Matthews J, Benson E, Page F, Bishop J. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group Blood. 1994;84(4):1220\u20135.","journal-title":"Australian Leukaemia Study Group Blood"},{"issue":"7","key":"1970_CR20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.6004\/jnccn.2017.0116","volume":"15","author":"MR O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Bhatt V, Bixby D, Blum W, Coutre SE, et al. Acute myeloid Leukemia, version 3.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(7):926\u201357.","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"1970_CR21","first-page":"388","volume":"8","author":"G Del Poeta","year":"1994","unstructured":"Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, et al. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia. 1994;8(3):388\u201394.","journal-title":"Leukemia"},{"issue":"2","key":"1970_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.blre.2005.08.002","volume":"20","author":"KD Mason","year":"2006","unstructured":"Mason KD, Juneja SK, Szer J. The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis? Blood Rev. 2006;20(2):71\u201382.","journal-title":"Blood Rev"},{"issue":"4","key":"1970_CR23","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173-180.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1970_CR24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2015.37","volume":"313","author":"M Fitzgerald","year":"2015","unstructured":"Fitzgerald M, Saville BR, Lewis RJ. Decision curve analysis. JAMA. 2015;313(4):409\u201310.","journal-title":"JAMA"},{"issue":"6","key":"1970_CR25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565\u201374.","journal-title":"Med Decis Making"},{"issue":"4","key":"1970_CR26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","volume":"10","author":"NJ Short","year":"2020","unstructured":"Short NJ, Konopleva M, Kadia TM, Borthakur G, Ravandi F, DiNardo CD, et al. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges. Cancer Discov. 2020;10(4):506\u201325.","journal-title":"Cancer Discov"},{"issue":"12","key":"1970_CR27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nchembio.116","volume":"4","author":"SZ Gadhoum","year":"2008","unstructured":"Gadhoum SZ, Sackstein R. CD15 expression in human myeloid cell differentiation is regulated by sialidase activity. Nat Chem Biol. 2008;4(12):751\u20137.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"1970_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10549-006-9286-9","volume":"101","author":"MT Elola","year":"2007","unstructured":"Elola MT, Capurro MI, Barrio MM, Coombs PJ, Taylor ME, Drickamer K, et al. Lewis x antigen mediates adhesion of human breast carcinoma cells to activated endothelium. Possible involvement of the endothelial scavenger receptor C-type lectin. Breast Cancer Res Treat. 2007;101(2):161\u201374.","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"1970_CR29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0301-472X(03)00237-6","volume":"31","author":"O Ohana-Malka","year":"2003","unstructured":"Ohana-Malka O, Benharroch D, Isakov N, Prinsloo I, Shubinsky G, Sacks M, et al. Selectins and anti-CD15 (Lewis x\/a) antibodies transmit activation signals in hodgkin\u2019s lymphoma-derived cell lines. Exp Hematol. 2003;31(11):1057\u201365.","journal-title":"Exp Hematol"},{"issue":"1","key":"1970_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1620\/tjem.163.17","volume":"163","author":"K Fukushima","year":"1991","unstructured":"Fukushima K. Expression of Lewis(x), sialylated Lewis(x), Lewis(a), and sialylated Lewis(a) antigens in human lung carcinoma. Tohoku J Exp Med. 1991;163(1):17\u201330.","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"1970_CR31","first-page":"913","volume":"45","author":"RH Riddell","year":"1985","unstructured":"Riddell RH, Listinsky CM. Expression of a carbohydrate differentiation antigen, stage-specific embryonic antigen 1, in human colonic adenocarcinoma. Cancer Res. 1985;45(2):913.","journal-title":"Cancer Res"},{"key":"1970_CR32","volume":"65","author":"GL Uy","year":"2024","unstructured":"Uy GL, DeAngelo DJ, Lozier JN, Fisher DM, Jonas BA, Magnani JL, et al. Targeting hematologic malignancies by inhibiting E-selectin: a sweet spot for AML therapy? Blood Rev. 2024;65:101184.","journal-title":"Blood Rev"},{"key":"1970_CR33","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1749-6632.2002.tb04702.x","volume":"973","author":"J Laferriere","year":"2002","unstructured":"Laferriere J, Houle F, Huot J. Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2\/p38. Ann N Y Acad Sci. 2002;973:562\u201372.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1970_CR34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1989.tb07677.x","volume":"72","author":"L Campos","year":"1989","unstructured":"Campos L, Guyotat D, Archimbaud E, Devaux Y, Treille D, Larese A, et al. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Br J Haematol. 1989;72(2):161\u20136.","journal-title":"Br J Haematol"},{"issue":"1","key":"1970_CR35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0165-4608(95)00084-4","volume":"84","author":"HF Tien","year":"1995","unstructured":"Tien HF, Wang CH, Lin MT, Lee FY, Liu MC, Chuang SM, et al. Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and Ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan. Cancer Genet Cytogenet. 1995;84(1):60\u20138.","journal-title":"Cancer Genet Cytogenet"},{"issue":"7","key":"1970_CR36","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/10428190802123994","volume":"49","author":"AR Derolf","year":"2008","unstructured":"Derolf AR, Bj\u00f6rklund E, Mazur J, Bj\u00f6rkholm M, Porwit A. Expression patterns of CD33 and CD15 predict outcome in patients with acute myeloid leukemia. Leuk Lymphoma. 2008;49(7):1279\u201391.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"1970_CR37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.leukres.2013.11.008","volume":"38","author":"M Breccia","year":"2014","unstructured":"Breccia M, De Propris MS, Minotti C, Stefanizzi C, Raponi S, Colafigli G, et al. Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patients. Leuk Res. 2014;38(2):194\u20137.","journal-title":"Leuk Res"},{"issue":"10","key":"1970_CR38","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.humpath.2013.03.007","volume":"44","author":"H Dang","year":"2013","unstructured":"Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia. Hum Pathol. 2013;44(10):2038\u201346.","journal-title":"Hum Pathol"},{"issue":"4","key":"1970_CR39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/cyto.b.21979","volume":"100","author":"M Gupta","year":"2021","unstructured":"Gupta M, Jafari K, Rajab A, Wei C, Mazur J, Tierens A, et al. Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1\u2009+\u2009acute myeloid leukemia by flow cytometry. Cytometry B Clin Cytom. 2021;100(4):409\u201320.","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"1970_CR40","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-04-1816","volume":"11","author":"LI Lin","year":"2005","unstructured":"Lin LI, Chen CY, Lin DT, Tsay W, Tang JL, Yeh YC, et al. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Clin Cancer Res. 2005;11(4):1372\u20139.","journal-title":"Clin Cancer Res"},{"issue":"26","key":"1970_CR41","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1182\/blood-2009-05-223784","volume":"114","author":"JL Tang","year":"2009","unstructured":"Tang JL, Hou HA, Chen CY, Liu CY, Chou WC, Tseng MH, et al. AML1\/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood. 2009;114(26):5352\u201361.","journal-title":"Blood"},{"key":"1970_CR42","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.","journal-title":"BMJ"},{"issue":"6","key":"1970_CR43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/PAI.0b013e318292b764","volume":"22","author":"R R\u00f8ge","year":"2014","unstructured":"R\u00f8ge R, Nielsen S, Vyberg M. Carb-3 is the superior anti-CD15 monoclonal antibody for immunohistochemistry. Appl Immunohistochem Mol Morphol. 2014;22(6):449\u201358.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"1970_CR44","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/ERC-16-0569","volume":"24","author":"J Munkley","year":"2017","unstructured":"Munkley J. Glycosylation is a global target for androgen control in prostate cancer cells. Endocr Relat Cancer. 2017;24(3):R49\u201364.","journal-title":"Endocr Relat Cancer"},{"key":"1970_CR45","volume":"52","author":"R Zhang","year":"2025","unstructured":"Zhang R, Zhao Y, Chai X, Wang Y, Zhao M, Guo S, et al. Modified CD15\/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia. Transl Oncol. 2025;52:102225.","journal-title":"Transl Oncol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01970-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:29:49Z","timestamp":1767677389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01970-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01970-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5905422\/v1","asserted-by":"object"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the institutional ethics committees of the Southwest Hospital and the First Affiliated Hospital of Chongqing Medical University (KY 2020\u2009\u2212\u2009199; NO 2021\u2009\u2212\u2009342).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"84"}}